Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance | Zendy

J. Peter Cegielski | Zendy; Ekaterina V. Kurbatova | Zendy; Martie van der Walt | Zendy; Jeannette Brand | Zendy; Julia Ershova | Zendy; Thelma E. Tupasi | Zendy; Janice Caoili | Zendy; Tracy Dalton | Zendy; Carmen Contreras | Zendy; Martín Yagui | Zendy; Jaime Bayona | Zendy; Charlotte Kvasnovsky | Zendy; Vaira Leimane | Zendy; Līga Kukša | Zendy; Michael P. Chen | Zendy; Laura E. Via | Zendy; Soo Hee Hwang | Zendy; Melanie Wolfgang | Zendy; Grigory Volchenkov | Zendy; Tatiana R. Somova | Zendy; Sarah E. Smith | Zendy; Somsak Akksilp | Zendy; Wanpen Wattanaamornkiet | Zendy; Hee Jin Kim | Zendy; Changki Kim | Zendy; Boris Y. Kazennyy | Zendy; Tatiana Khorosheva | Zendy; Kai Kliiman | Zendy; Piret Viiklepp | Zendy; Ruwen Jou | Zendy; Angela Huang | Zendy; I. А. Vаsilyevа | Zendy; Olga V. Demikhova | Zendy; Joey Lancaster | Zendy; Ronel Odendaal | Zendy; Lois Diem | Zendy; Maria T. Perez | Zendy; Tarcela Gler | Zendy; K K Tan | Zendy; César Antonio Bonilla-Asalde | Zendy; Oswaldo Jave | Zendy; Luis Asencios | Zendy; Gloria Yale | Zendy; Carmen Suárez | Zendy; Allison Taylor Walker | Zendy; Inga Norvaisha | Zendy; Ģirts Šķenders | Zendy; Ingrida Sture | Zendy; Vija Riekstiņa | Zendy; Andra Cīrule | Zendy; Erika Sigman | Zendy; Sang Nae Cho | Zendy; Ying Cai | Zendy; SeokYong Eum | Zendy; Jongseok Lee | Zendy; Seung-Kyu Park | Zendy; Doosoo Jeon | Zendy; Isdore Chola Shamputa | Zendy; Beverly Metchock | Zendy; Tatiana Kuznetsova | Zendy; Rattanawadee Akksilp | Zendy; Wanlaya Sitti | Zendy; Jirapan Inyapong | Zendy; E. V. Kiryanova | Zendy; I. I. Degtyareva | Zendy; Evgenia S. Nemtsova | Zendy; Klavdia Levina | Zendy; Manfred Danilovitš | Zendy; Tiina Kummik | Zendy; Yung-Chao Lei | Zendy; Weilun Huang | Zendy; В В Ерохин | Zendy; Л. Н. Черноусова | Zendy; Sofia N. Andreevskaya | Zendy; Elena Larionova | Zendy; Tatyana Smirnova | Zendy

Open Access

Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance

Author(s) -

J. Peter Cegielski,

Ekaterina V. Kurbatova,

Martie van der Walt,

Jeannette Brand,

Julia Ershova,

Thelma E. Tupasi,

Janice Caoili,

Tracy Dalton,

Carmen Contreras,

Martín Yagui,

Jaime Bayona,

Charlotte Kvasnovsky,

Vaira Leimane,

Līga Kukša,

Michael P. Chen,

Laura E. Via,

Soo Hee Hwang,

Melanie Wolfgang,

Grigory Volchenkov,

Tatiana R. Somova,

Sarah E. Smith,

Somsak Akksilp,

Wanpen Wattanaamornkiet,

Hee Jin Kim,

Changki Kim,

Boris Y. Kazennyy,

Tatiana Khorosheva,

Kai Kliiman,

Piret Viiklepp,

Ruwen Jou,

Angela Huang,

I. А. Vаsilyevа,

Olga V. Demikhova,

Joey Lancaster,

Ronel Odendaal,

Lois Diem,

Maria T. Perez,

Tarcela Gler,

K K Tan,

César Antonio Bonilla-Asalde,

Oswaldo Jave,

Luis Asencios,

Gloria Yale,

Carmen Suárez,

Allison Taylor Walker,

Inga Norvaisha,

Ģirts Šķenders,

Ingrida Sture,

Vija Riekstiņa,

Andra Cīrule,

Erika Sigman,

Sang Nae Cho,

Ying Cai,

SeokYong Eum,

Jongseok Lee,

Seung-Kyu Park,

Doosoo Jeon,

Isdore Chola Shamputa,

Beverly Metchock,

Tatiana Kuznetsova,

Rattanawadee Akksilp,

Wanlaya Sitti,

Jirapan Inyapong,

E. V. Kiryanova,

I. I. Degtyareva,

Evgenia S. Nemtsova,

Klavdia Levina,

Manfred Danilovitš,

Tiina Kummik,

Yung-Chao Lei,

Weilun Huang,

В В Ерохин,

Л. Н. Черноусова,

Sofia N. Andreevskaya,

Elena Larionova,

Tatyana Smirnova

Publication year - 2015

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ910

Subject(s) - medicine , tuberculosis , drug resistance , odds ratio , sputum , multiple drug resistance , extensively drug resistant tuberculosis , confidence interval , drug , surgery , pharmacology , mycobacterium tuberculosis , pathology , microbiology and biotechnology , biology

Resistance to second-line drugs develops during treatment of multidrug-resistant (MDR) tuberculosis, but the impact on treatment outcome has not been determined.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research